Cipla licenses HIV drugs to Russia | Chemical & Engineering News
Volume 94 Issue 26 | p. 12 | Concentrates
Issue Date: June 27, 2016

Cipla licenses HIV drugs to Russia

Department: Business
Keywords: generics, HIV, antiretroviral, hepatitis, Russia

India’s Cipla has signed a memorandum of understanding with the Russian firm National Immunobiological Co. (Nacimbio) concerning the use of Cipla technology for Russian manufacturing of antiviral drugs to treat HIV and hepatitis C. Russia currently does not produce the treatments. Investment on the project will approach $45 million, Nacimbio says. Cipla is one of the world’s largest producers of HIV drugs.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment